Search

everythinglearnresearchcommunity

for

Search:↓

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

Estrogen alone can lower testosterone in some transfeminine people.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Progesterone may help trans women with breast development and health, but more research is needed.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Transgender treatment includes hormones and surgery, but long-term effects are unknown and counseling is needed.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Proper planning and technique in upper-face feminization surgery are crucial to avoid complications and revisions.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.